Longevity Life Sciences partners Mitsubishi Gas Chemical to expand cellular health platform

Singapore, Aug. 28 -- Australian cellular health company Longevity Life Sciences has entered into a multi-year strategic partnership with Mitsubishi Gas Chemical to bring a pipeline of pharmaceutical-... Read More

Kazia reports 100% clinical benefit rate in initial patients with advanced triple-negative breast cancer

Singapore, Aug. 28 -- Australian oncology biotechnology company Kazia Therapeutics has reported a 100% clinical benefit rate among the first six evaluable patients treated with paxalisib in a study in... Read More

First patient dosed in Australian KOALA CAR-T trial for multiple myeloma

Singapore, Aug. 27 -- Cell Therapies has manufactured and released the first clinical dose for the KOALA trial, a first-in-human study evaluating a novel CAR T-cell therapy in patients with relapsed o... Read More

Cytrellis launches full-body skin resurfacing technology in Australia

Singapore, Aug. 27 -- Cytrellis Biosystems, Inc., a medical aesthetics company bridging the gap in skin health and restoration, has announced the commercial launch of ellacor(R) with Micro-Coring Tech... Read More

PolyU and University of Oxford forge strategic partnerships to advance academic collaboration

Singapore, Aug. 27 -- The Hong Kong Polytechnic University (PolyU) and the University of Oxford, UK have signed a Memorandum of Understanding (MoU) at the University of Oxford, to foster pioneering ac... Read More

Singapore's MuseCell Innovations announces manufacturing collaboration with Celularity in US

Singapore, Aug. 27 -- US-based Celularity Inc., a longevity-focused regenerative and cellular medicine company, and Singaporean startup MuseCell Innovations(R) (MCI), the owner of the Dezawa MuseCell ... Read More

Singapore designs bioinspired nanoparticles that deliver gene editing to lower bad cholesterol

Singapore, Aug. 26 -- Researchers from the National University of Singapore (NUS) Medicine and China's Tianjin Medical University General Hospital have developed a bioinspired lipid nanoparticle (LNP)... Read More

Advent acquires majority stake in New Zealand Clinical Research Group

Singapore, Aug. 26 -- US-based Advent, a leading global private equity investor, has signed a definitive agreement to acquire a majority shareholding in New Zealand Clinical Research Group (NZCR Group... Read More

China's Haisco Pharma enters into agreement worth $1.5 B with US-based Sentivera

Singapore, Aug. 26 -- Haisco Pharmaceutical Group Co. has entered into an exclusive licensing agreement with Sentivera, a new US venture founded by Population Health Partners (PHP) and ARCH Venture Pa... Read More

Shimadzu invests in OptQC to advance next-generation R&D infrastructure for drug discovery

Singapore, Aug. 26 -- Japan-based Shimadzu Corporation has invested in OptQC Inc., a startup originating from The University of Tokyo, through its Corporate Venture Capital (CVC) fund, "Shimadzu Futur... Read More

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»